Literature DB >> 25758998

Genome-wide genetic investigation of serological measures of common infections.

Rohina Rubicz1, Robert Yolken2, Eugene Drigalenko3, Melanie A Carless3, Thomas D Dyer3, Jack Kent3, Joanne E Curran3, Matthew P Johnson3, Shelley A Cole3, Sharon P Fowler4, Rector Arya5, Sobha Puppala3, Laura Almasy3, Eric K Moses6, Ellen Kraig7, Ravindranath Duggirala3, John Blangero3, Charles T Leach8, Harald H H Göring3.   

Abstract

Populations and individuals differ in susceptibility to infections because of a number of factors, including host genetic variation. We previously demonstrated that differences in antibody titer, which reflect infection history, are significantly heritable. Here we attempt to identify the genetic factors influencing variation in these serological phenotypes. Blood samples from >1300 Mexican Americans were quantified for IgG antibody level against 12 common infections, selected on the basis of their reported role in cardiovascular disease risk: Chlamydia pneumoniae; Helicobacter pylori; Toxoplasma gondii; cytomegalovirus; herpes simplex I virus; herpes simplex II virus; human herpesvirus 6 (HHV6); human herpesvirus 8 (HHV8); varicella zoster virus; hepatitis A virus (HAV); influenza A virus; and influenza B virus. Pathogen-specific quantitative antibody levels were analyzed, as were three measures of pathogen burden. Genome-wide linkage and joint linkage and association analyses were performed using ~1 million SNPs. Significant linkage (lod scores >3.0) was obtained for HHV6 (on chromosome 7), HHV8 (on chromosome 6), and HAV (on chromosome 13). SNP rs4812712 on chromosome 20 was significantly associated with C. pneumoniae (P=5.3 × 10(-8)). However, no genome-wide significant loci were obtained for the other investigated antibodies. We conclude that it is possible to localize host genetic factors influencing some of these antibody traits, but that further larger-scale investigations will be required to elucidate the genetic mechanisms contributing to variation in antibody levels.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25758998      PMCID: PMC4613484          DOI: 10.1038/ejhg.2015.24

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  33 in total

1.  Genomic control for association studies.

Authors:  B Devlin; K Roeder
Journal:  Biometrics       Date:  1999-12       Impact factor: 2.571

2.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

3.  A role for genetics in the immune response to the varicella vaccine.

Authors:  Nicola P Klein; Bruce Fireman; Andrea Enright; Paula Ray; Steven Black; Cornelia L Dekker
Journal:  Pediatr Infect Dis J       Date:  2007-04       Impact factor: 2.129

4.  Markov chain Monte Carlo segregation and linkage analysis for oligogenic models.

Authors:  S C Heath
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

5.  MCMC segregation and linkage analysis.

Authors:  S C Heath; G L Snow; E A Thompson; C Tseng; E M Wijsman
Journal:  Genet Epidemiol       Date:  1997       Impact factor: 2.135

6.  Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study.

Authors:  B D Mitchell; C M Kammerer; J Blangero; M C Mahaney; D L Rainwater; B Dyke; J E Hixson; R D Henkel; R M Sharp; A G Comuzzie; J L VandeBerg; M P Stern; J W MacCluer
Journal:  Circulation       Date:  1996-11-01       Impact factor: 29.690

7.  Estimation of the variance components for dermal ridge count.

Authors:  M A Spence; J Westlake; K Lange
Journal:  Ann Hum Genet       Date:  1977-07       Impact factor: 1.670

8.  Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels.

Authors:  J Zhu; A A Quyyumi; J E Norman; G Csako; M A Waclawiw; G M Shearer; S E Epstein
Journal:  Am J Cardiol       Date:  2000-01-15       Impact factor: 2.778

9.  Genetic epidemiology of seropositivity for Trypanosoma cruzi infection in rural Goias, Brazil.

Authors:  S Williams-Blangero; J L Vandeberg; J Blangero; A R Teixeira
Journal:  Am J Trop Med Hyg       Date:  1997-11       Impact factor: 2.345

10.  Seroprevalence of 13 common pathogens in a rapidly growing U.S. minority population: Mexican Americans from San Antonio, TX.

Authors:  Rohina Rubicz; Charles T Leach; Ellen Kraig; Nikhil V Dhurandhar; Barry Grubbs; John Blangero; Robert Yolken; Harald Hh Göring
Journal:  BMC Res Notes       Date:  2011-10-21
View more
  11 in total

1.  Analysis of antibody binding specificities in twin and SNP-genotyped cohorts reveals that antiviral antibody epitope selection is a heritable trait.

Authors:  Thiagarajan Venkataraman; Cristian Valencia; Massimo Mangino; William Morgenlander; Steven J Clipman; Thomas Liechti; Ana Valencia; Paraskevi Christofidou; Tim Spector; Mario Roederer; Priya Duggal; H Benjamin Larman
Journal:  Immunity       Date:  2022-01-11       Impact factor: 43.474

2.  Association of 4p14 TLR locus with antibodies to Helicobacter pylori.

Authors:  H Sung; M C Camargo; K Yu; S J Weinstein; D R Morgan; D Albanes; C S Rabkin
Journal:  Genes Immun       Date:  2015-08-27       Impact factor: 2.676

3.  Human genetic variants and age are the strongest predictors of humoral immune responses to common pathogens and vaccines.

Authors:  Petar Scepanovic; Cécile Alanio; Christian Hammer; Flavia Hodel; Jacob Bergstedt; Etienne Patin; Christian W Thorball; Nimisha Chaturvedi; Bruno Charbit; Laurent Abel; Lluis Quintana-Murci; Darragh Duffy; Matthew L Albert; Jacques Fellay
Journal:  Genome Med       Date:  2018-07-27       Impact factor: 11.117

Review 4.  Host Genetics of Cytomegalovirus Pathogenesis.

Authors:  Efe Sezgin; Ping An; Cheryl A Winkler
Journal:  Front Genet       Date:  2019-07-23       Impact factor: 4.599

Review 5.  Co-Occurrence of Hepatitis A Infection and Chronic Liver Disease.

Authors:  Tatsuo Kanda; Reina Sasaki; Ryota Masuzaki; Hiroshi Takahashi; Taku Mizutani; Naoki Matsumoto; Kazushige Nirei; Mitsuhiko Moriyama
Journal:  Int J Mol Sci       Date:  2020-09-02       Impact factor: 5.923

6.  Inter-individual variability and genetic influences on cytokine responses to bacteria and fungi.

Authors:  Yang Li; Marije Oosting; Patrick Deelen; Isis Ricaño-Ponce; Sanne Smeekens; Martin Jaeger; Vasiliki Matzaraki; Morris A Swertz; Ramnik J Xavier; Lude Franke; Cisca Wijmenga; Leo A B Joosten; Vinod Kumar; Mihai G Netea
Journal:  Nat Med       Date:  2016-07-04       Impact factor: 53.440

Review 7.  The complement system: a gateway to gene-environment interactions in schizophrenia pathogenesis.

Authors:  V L Nimgaonkar; K M Prasad; K V Chowdari; E G Severance; R H Yolken
Journal:  Mol Psychiatry       Date:  2017-08-01       Impact factor: 15.992

8.  Herpes simplex virus: global infection prevalence and incidence estimates, 2016.

Authors:  Charlotte James; Manale Harfouche; Nicky J Welton; Katherine Me Turner; Laith J Abu-Raddad; Sami L Gottlieb; Katharine J Looker
Journal:  Bull World Health Organ       Date:  2020-03-25       Impact factor: 9.408

Review 9.  Schizophrenia and Influenza at the Centenary of the 1918-1919 Spanish Influenza Pandemic: Mechanisms of Psychosis Risk.

Authors:  Adrianna P Kępińska; Conrad O Iyegbe; Anthony C Vernon; Robert Yolken; Robin M Murray; Thomas A Pollak
Journal:  Front Psychiatry       Date:  2020-02-26       Impact factor: 4.157

10.  Distinct genetic architectures and environmental factors associate with host response to the γ2-herpesvirus infections.

Authors:  Robert Newton; Denise Whitby; Inês Barroso; Neneh Sallah; Wendell Miley; Nazzarena Labo; Tommy Carstensen; Segun Fatumo; Deepti Gurdasani; Martin O Pollard; Alexander T Dilthey; Alexander J Mentzer; Vickie Marshall; Elena M Cornejo Castro; Cristina Pomilla; Elizabeth H Young; Gershim Asiki; Martin L Hibberd; Manjinder Sandhu; Paul Kellam
Journal:  Nat Commun       Date:  2020-07-31       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.